COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING MARINE FUNGUS PENICILLIUM SP. SF-5859-DERIVED CURVULARIN-TYPE METABOLITES
申请人:KOREA INSITITUTE OF OCEAN SCIENCE AND TECHNOLOGY
公开号:US20210177796A1
公开(公告)日:2021-06-17
The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases and a food for preventing or alleviating inflammatory diseases, both of which contain curvularin-type metabolites as an active ingredient and, more specifically to a pharmaceutical composition for preventing or treating inflammatory diseases and a food for preventing or alleviating inflammatory diseases, both of which contain, as an active ingredient, marine fungus
Penicillium
sp. SF-5859-derived curvularin-type metabolites. A pharmaceutical composition, according to the present invention, for preventing or treating inflammatory diseases, containing curvularin-type metabolites derived from marine fungus
Penicillium
sp. SF-5859 (KCTC 13354 BP) inhibits the production of proinflammatory cytokines and mediators, thereby being effectively usable for the prevention or treatment of inflammatory diseases.